353 related articles for article (PubMed ID: 37446064)
1. Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Tabanelli R; Brogi S; Calderone V
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446064
[TBL] [Abstract][Full Text] [Related]
2. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
Pergolizzi JV; Raffa RB; Rosenblatt MH
J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
[TBL] [Abstract][Full Text] [Related]
3. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.
Kudrich C; Hurd YL; Salsitz E; Wang AL
Cannabis Cannabinoid Res; 2022 Oct; 7(5):569-581. PubMed ID: 34678050
[No Abstract] [Full Text] [Related]
5. Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder.
Lee YK; Gold MS; Fuehrlein BS
J Neurol Sci; 2022 Jan; 432():120094. PubMed ID: 34933249
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM; Pepin MJ; Brown JN
J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
[TBL] [Abstract][Full Text] [Related]
7. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.
Christie MJ
Br J Pharmacol; 2008 May; 154(2):384-96. PubMed ID: 18414400
[TBL] [Abstract][Full Text] [Related]
8. The Role of Opioid Receptors in Cancer.
Bhoir S; Uhelski M; Guerra-Londono JJ; Cata JP
Adv Biol (Weinh); 2023 Jul; 7(7):e2300102. PubMed ID: 37132160
[TBL] [Abstract][Full Text] [Related]
9. Opioid withdrawal: role in addiction and neural mechanisms.
Monroe SC; Radke AK
Psychopharmacology (Berl); 2023 Jul; 240(7):1417-1433. PubMed ID: 37162529
[TBL] [Abstract][Full Text] [Related]
10. New directions in the treatment of opioid withdrawal.
Srivastava AB; Mariani JJ; Levin FR
Lancet; 2020 Jun; 395(10241):1938-1948. PubMed ID: 32563380
[TBL] [Abstract][Full Text] [Related]
11. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
Bisaga A; Mannelli P; Sullivan MA; Vosburg SK; Compton P; Woody GE; Kosten TR
Am J Addict; 2018 Apr; 27(3):177-187. PubMed ID: 29596725
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
[TBL] [Abstract][Full Text] [Related]
13. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy.
Harun N; Kamaruzaman NA; Mohamed Sofian Z; Hassan Z
Neurosci Lett; 2022 Mar; 773():136500. PubMed ID: 35114335
[TBL] [Abstract][Full Text] [Related]
14. Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.
Benéitez MC; Gil-Alegre ME
Biomed Res Int; 2017; 2017():7120815. PubMed ID: 28607934
[TBL] [Abstract][Full Text] [Related]
15. Clinical Management of Opioid Withdrawal.
Torres-Lockhart KE; Lu TY; Weimer MB; Stein MR; Cunningham CO
Addiction; 2022 Sep; 117(9):2540-2550. PubMed ID: 35112746
[TBL] [Abstract][Full Text] [Related]
16. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
17. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.
Walwyn WM; Miotto KA; Evans CJ
Drug Alcohol Depend; 2010 May; 108(3):156-65. PubMed ID: 20188495
[TBL] [Abstract][Full Text] [Related]
18. Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal Symptoms.
Lambert TP; Gazi AH; Harrison AB; Gharehbaghi S; Chan M; Obideen M; Alavi P; Murrah N; Shallenberger L; Driggers EG; Alvarado Ortega R; Washington B; Walton KM; Tang YL; Gupta R; Nye JA; Welsh JW; Vaccarino V; Shah AJ; Bremner JD; Inan OT
Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354433
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
20. Chronic Pain, Chronic Opioid Addiction: a Complex Nexus.
Salsitz EA
J Med Toxicol; 2016 Mar; 12(1):54-7. PubMed ID: 26602212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
